The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•17 April 2026•

1 min read

Mixed Nasdaq Developments: Coeptis Merger Advances as Visionary Holdings Faces Compliance Issues

A world map in golden tones with overlaid financial charts showing a downward trend, a large blue arrow pointing down, and falling circuit boards and text. Two screens display NASDAQ data.

Key Facts

1Z Squared Inc. received approval for its Nasdaq listing application, satisfying a key closing condition for its merger with Coeptis.

Nasdaq recently witnessed divergent paths for two listed entities, starting with Coeptis Therapeutics Holdings Inc, which moved closer to finalizing its merger. This progress follows the formal Nasdaq listing approval for Z Squared Inc, satisfying a critical closing condition for the transaction. Conversely, Visionary Holdings Inc (Nasdaq: GV) is facing regulatory headwinds after receiving a deficiency notice from the Nasdaq Listing Qualifications Department. The notice stems from the company's failure to comply with Rule 5250(c)(1) regarding the timely filing of periodic financial reports. While the news provides a bullish catalyst for Coeptis due to merger clarity, it presents a bearish outlook for Visionary Holdings as delisting risks loom. Market participants are now focusing on Visionary's ability to regain compliance while tracking the final integration steps for Coeptis.